Anticonvulsant effect of AMP by direct activation of adenosine A1 receptor

Experimental Neurology

Volumn 250, Issue , 2013, Pages 189-193

  Muzzi, Mirko ^a   Coppi, Elisabetta ^a   Pugliese, Anna Maria ^a   Chiarugi, Alberto ^a  

^a UNIVERSITY OF FLORENCE   (Italy)

Author keywords

A1 receptors; Adenosine; AMP; Epilepsy

Indexed keywords

8 CYCLOPENTYL 1,3 DIPROPYLXANTHINE; ADENOSINE; ADENOSINE A1 RECEPTOR; ADENOSINE PHOSPHATE; KAINIC ACID; MAGNESIUM ION;

ADRENERGIC TRANSMISSION; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTICONVULSANT ACTIVITY; ARTICLE; BRAIN SLICE; CONTROLLED STUDY; CONVULSION; DISEASE SEVERITY; DOSE RESPONSE; EPILEPSY; EPILEPTIC DISCHARGE; HIPPOCAMPAL CA1 REGION; IN VITRO STUDY; IN VIVO STUDY; LATENT PERIOD; MALE; MOUSE; NERVE CELL EXCITABILITY; NERVE CELL MEMBRANE POTENTIAL; NEUROMODULATION; NONHUMAN; PHARMACOLOGICAL STIMULATION; PRIORITY JOURNAL; SEIZURE; TREATMENT OUTCOME;

A1 RECEPTORS; ADENOSINE; AMP; EPILEPSY;

ADENOSINE A1 RECEPTOR AGONISTS; ADENOSINE A1 RECEPTOR ANTAGONISTS; ADENOSINE MONOPHOSPHATE; ANIMALS; ANTICONVULSANTS; CA1 REGION, HIPPOCAMPAL; DISEASE MODELS, ANIMAL; EPILEPSY; MALE; MICE; MICE, INBRED C57BL; MICE, INBRED DBA; ORGAN CULTURE TECHNIQUES; RECEPTOR, ADENOSINE A1; XANTHINES;

EID: 84885816676     PISSN: 00144886     EISSN: 10902430     Source Type: Journal    
DOI: 10.1016/j.expneurol.2013.09.010     Document Type: Article

References (21)

1. Anderson W.W., Collingridge G.L. The LTP Program: a data acquisition program for on-line analysis of long-term potentiation and other synaptic events. J. Neurosci. Methods 2001, 108:71-83.
2. Boison D. Adenosine as a neuromodulator in neurological diseases. Curr. Opin. Pharmacol. 2008, 8:2-7.
3. Boison D. Modulators of nucleoside metabolism in the therapy of brain diseases. Curr. Top. Med. Chem. 2011, 11:1068-1086.
4. Camici M., Micheli V., Ipata P.L., Tozzi M.G. Pediatric neurological syndromes and inborn errors of purine metabolism. Neurochem. Int. 2010, 56:367-378.
5. Chen J.F., Eltzschig H.K., Fredholm B.B. Adenosine receptors as drug targets - what are the challenges?. Nat. Rev. Drug Discovery 2013, 12:265-286.
6. De S.G., Donato Di P.E., Falconi U., Ferreri G., De S.A. Repeated treatment with adenosine A1 receptor agonist and antagonist modifies the anticonvulsant properties of CPPene. Eur. J. Pharmacol. 1996, 317:239-245.
7. During M.J., Spencer D.D. Adenosine: a potential mediator of seizure arrest and postictal refractoriness. Ann. Neurol. 1992, 32:618-624.
8. Fedele D.E., Li T., Lan J.Q., Fredholm B.B., Boison D. Adenosine A1 receptors are crucial in keeping an epileptic focus localized. Exp. Neurol. 2006, 200:184-190.
9. Halassa M.M., Haydon P.G. Integrated brain circuits: astrocytic networks modulate neuronal activity and behavior. Annu. Rev. Physiol. 2010, 72:335-355.
10. Hamil N.E., Cock H.R., Walker M.C. Acute down-regulation of adenosine A(1) receptor activity in status epilepticus. Epilepsia 2012, 53:177-188.
11. Klyuch B.P., Dale N., Wall M.J. Deletion of ecto-5'-nucleotidase (CD73) reveals direct action potential-dependent adenosine release. J. Neurosci. 2012, 32:3842-3847.
12. Lovatt D., Xu Q., Liu W., Takano T., Smith N.A., Schnermann J., Tieu K., Nedergaard M. Neuronal adenosine release, and not astrocytic ATP release, mediates feedback inhibition of excitatory activity. Proc. Natl. Acad. Sci. U. S. A. 2012, 109:6265-6270.
13. Maitre M., Chesielski L., Lehmann A., Kempf E., Mandel P. Protective effect of adenosine and nicotinamide against audiogenic seizure. Biochem. Pharmacol. 1974, 23:2807-2816.
14. Melani A., Corti F., Stephan H., Muller C.E., Donati C., Bruni P., Vannucchi M.G., Pedata F. Ecto-ATPase inhibition: ATP and adenosine release under physiological and ischemic in vivo conditions in the rat striatum. Exp. Neurol. 2012, 233:193-204.
15. Muzzi M., Blasi F., Chiarugi A. AMP-dependent hypothermia affords protection from ischemic brain injury. J. Cereb. Blood Flow Metab. 2013, 33:171-174.
16. Muzzi M., Blasi F., Masi A., Coppi E., Traini C., Felici R., Pittelli M., Cavone L., Pugliese A.M., Moroni F., Chiarugi A. Neurological basis of AMP-dependent thermoregulation and its relevance to central and peripheral hyperthermia. J. Cereb. Blood Flow Metab. 2013, 33:183-190.
17. Pascual O., Casper K.B., Kubera C., Zhang J., Revilla-Sanchez R., Sul J.Y., Takano H., Moss S.J., McCarthy K., Haydon P.G. Astrocytic purinergic signaling coordinates synaptic networks. Science 2005, 310:113-116.
18. Rittiner J.E., Korboukh I., Hull-Ryde E.A., Jin J., Janzen W.P., Frye S.V., Zylka M.J. AMP is an adenosine A1 receptor agonist. J. Biol. Chem. 2012, 287:5301-5309.
19. Ross F.M., Brodie M.J., Stone T.W. Adenosine monophosphate as a mediator of ATP effects at P1 purinoceptors. Br. J. Pharmacol. 1998, 124:818-824.
20. Wyneken U., Smalla K.H., Marengo J.J., Soto D., de la Cerda A., Tischmeyer W., Grimm R., Boeckers T.M., Wolf G., Orrego F., Gundelfinger E.D. Kainate-induced seizures alter protein composition and N-methyl-D-aspartate receptor function of rat forebrain postsynaptic densities. Neuroscience 2001, 102:65-74.
21. Zhang J.M., Wang H.K., Ye C.Q., Ge W., Chen Y., Jiang Z.L., Wu C.P., Poo M.M., Duan S. ATP released by astrocytes mediates glutamatergic activity-dependent heterosynaptic suppression. Neuron 2003, 40:971-982.